Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2020 Issue has been successfully launched on 1 September 2020.

Abstract

INSILICO SCREENING STUDIES FOR THE IDENTIFICATION OF NOVEL INHIBITOR IN CARDIOVASCULAR DISEASES BY DRUG BANK DATABASE

M. Padmavathi

Department of Biotechnology, DVR & Dr. HS MIC College of Technology, Kanchikacherla, A.P, India.

ABSTRACT

Cardiovascular disease is the leading cause of deaths worldwide. Cardiovascular deaths and diseases have increased at a fast rate in lowand middle-income countries. HMGR catalyzes the synthesis of cholesterol. There are some naturally occurring inhibitors for CVD but affects the vascular and cardiac function. There are some proteins show correlation with dysfunction and cardiovascular risk, together with the associations between cardiac risk factors and protein levels, strong relationships which qualifies as a potential therapeutic target. By using virtual screening methods and Insilco tools, the induced fit of the active site upon binding of a known inhibitor was analyzed. The derived pharmacophore features were used to dock nearly 1000 molecules generated by Drug Bank databases. Binding affinity of the lead candidates obtained by docking were compared to that of the known inhibitors and found the best and much lower one. In the present article a series of 3 novel molecules i.e., lead compounds were identified which Fosampenavir was more effective as therapeutic agent to modulate the heart diseases associated with protein Fluvastatin levels.

Keywords: CVD, HMGR, Virtual screening, Docking, Target proteins, Novel Inhibitor.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More